Join to access to all OVN content. Join for Free
How to Prepare a Presentation for an MSL Interview with Kathy Gann
MSL interview preparation presentation tips MSL director insights interview advice Mallinckrodt and Syneos Health

How to Prepare a Presentation for an MSL Interview with Kathy Gann


Share This Article


Summary

In this episode, my guest is Kathy Gann. Kathy is a former MSL director of Mallinckrodt and Syneos Health and we talk about how to prepare a presentation for an MSL interview. Great information so anyone preparing for an interview should check this out.

In this episode:

  • Expect the unexpected
  • Three types of presentation
  • What are the interviewers listening for?
  • How much practice is required to ensure a GOOD presentation?
  • Advice for someone who gets a question they don’t have the answer
  • Interesting interview stories of presentations gone bad
  • Kathy’s advice for aspiring MSL candidates?

Click for Source
MSL interview preparation, presentation tips, MSL director insights, interview advice, Mallinckrodt and Syneos Health

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
How I landed my first MSL role... what works, what doesn't, and what you need to know
Partner Avatar MSL Talk: Tom Caravela, Julie Chen

How I landed my first MSL role... what works, what doesn't, and what you need to know

Podcast
How to Prepare and Succeed on a Video Interview
Partner Avatar MSL Talk: Tom Caravela, Laura Wilson, MD

How to Prepare and Succeed on a Video Interview

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Explore OVN